Target Name: XCL1
NCBI ID: G6375
Other Name(s): SCM-1 | single cysteine motif 1a | Lymphotactin | small-inducible cytokine C1 | LPTN | Cytokine SCM-1 | SCM-1-alpha | XC chemokine ligand 1 | Lymphotaxin | cytokine SCM-1 | lymphotaxin | SCM1 | LTN | c motif chemokine 1 | SCM1A | chemokine (C motif) ligand 1 | XCL1_HUMAN | Small inducible cytokine subfamily C, member 1 (lymphotactin) | C motif chemokine 1 | SCYC1 | ATAC | SCM-1a | Small-inducible cytokine C1 | small inducible cytokine subfamily C, member 1 (lymphotactin) | X-C motif chemokine ligand 1

Understanding XCL1: A Potential Drug Target and Biomarker

XCL1 (also known as SCM-1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.

XCL1 has been shown to play a role in a number of important biological processes in the body, including the regulation of inflammation, blood vessel formation, and cell signaling. It is also involved in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

As a drug target, XCL1 is a promising target for a number of different diseases. For example, studies have shown that inhibiting XCL1 can reduce the growth and spread of cancer cells, and may also be effective in treating neurodegenerative diseases such as Alzheimer's and Parkinson's.

In addition to its potential as a drug target, XCL1 is also a potential biomarker for a number of diseases. Its expression has been shown to be elevated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, its levels have been shown to be correlated with the severity of certain diseases, such as heart failure in patients with cancer.

Despite the potential benefits of XCL1 as a drug target and biomarker, much more research is needed to fully understand its role in the body and its potential applications. continue to be explored. As research continues, it is likely that XCL1 will continue to be an important target for new drugs and therapies, and its potential as a biomarker for a number of diseases will also be discovered.

Protein Name: X-C Motif Chemokine Ligand 1

Functions: Chemotactic activity for lymphocytes but not for monocytes or neutrophils. In thymus, mediates medullary accumulation of thymic dendritic cells and contributes to regulatoy T cell development, playing a role in self-tolerance establishment

More Common Targets

XCL2 | XCR1 | XDH | XG | XGY2 | XIAP | XIRP1 | XIRP2 | XIST | XK | XKR3 | XKR4 | XKR5 | XKR6 | XKR7 | XKR8 | XKR9 | XKRX | XKRY | XKRYP7 | XLOC_007697 | XLOC_008559 | XLOC_009911 | XNDC1N | XPA | XPC | XPC complex | XPNPEP1 | XPNPEP2 | XPNPEP3 | XPO1 | XPO4 | XPO5 | XPO6 | XPO7 | XPOT | XPR1 | XRCC1 | XRCC2 | XRCC3 | XRCC4 | XRCC5 | XRCC6 | XRCC6P5 | XRN1 | XRN2 | XRRA1 | XXYLT1 | XXYLT1-AS2 | XYLB | XYLT1 | XYLT2 | YAE1 | YAF2 | YAP1 | YARS1 | YARS2 | YBEY | YBX1 | YBX1P1 | YBX1P10 | YBX1P2 | YBX1P4 | YBX2 | YBX3 | YBX3P1 | YDJC | YEATS2 | YEATS4 | YES1 | YIF1A | YIF1B | YIPF1 | YIPF2 | YIPF3 | YIPF4 | YIPF5 | YIPF6 | YIPF7 | YJEFN3 | YJU2 | YJU2B | YKT6 | YLPM1 | YME1L1 | YOD1 | YPEL1 | YPEL2 | YPEL3 | YPEL3-DT | YPEL4 | YPEL5 | YRDC | YTHDC1 | YTHDC2 | YTHDF1 | YTHDF2 | YTHDF3 | YWHAB | YWHABP1